NICE and BHS to review hypertension guidelines after ASCOT
NICE and the British Hypertension Society are to review the current guidelines for the management of hypertension following the findings of ASCOT-BPLA (Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm) which showed that treatment with amplodipine and perindopril was better than atenolol and bendroflumethiazide.
NICE 2005/026
The early review of the guidelines is likely to place a more prominent role for calcium antagonists particularly in those patients with complicated hypertension such as in those with diabetes.
